Hundreds sue GLP-1 drug makers over alleged vision loss
Summarised from 3 outlets · Updated 24 Sept, 18:08 · Archive
Hundreds of consumers are suing makers of GLP-1 weight-loss drugs, claiming they caused vision loss.
More than 90 lawsuits have been filed against GLP-1 drug companies, with consumers alleging that drugs such as Ozempic and Wegovy caused NAION, a rare eye condition involving sudden reduction in blood flow to the optic nerve that results in sudden vision loss. The lawsuits claim the diabetes and weight-loss drugs are responsible for the rare eye condition.
How it is being reported
- GLP-1 drugs increase rare ‘eye stroke’ linked to vision loss, hundreds of lawsuits allegeNAION is a rare eye condition in which blood flow to the optic nerve is suddenly reduced, leading to sudden vision loss.New York Post · 24 Sept, 17:55
- Popular weight-loss drugs face numerous lawsuits over rare ‘eye stroke’ linked to vision lossHundreds of consumers allege GLP-1 drugs like Ozempic and Wegovy caused NAION, a rare eye stroke linked to sudden, often permanent vision loss.Fox News · 22 Sept, 20:38
- Dozens of people sue GLP-1 drug companies over alleged vision lossMore than 90 lawsuits against GLP-1 companies claim rare eye condition resulted from diabetes and weight loss drugs.Al Jazeera · 22 Sept, 16:23
In this story: Ozempic · Wegovy
This summary was written by AI from the headlines and standfirsts above, and states as fact only what at least two outlets report. How we use AI · Report a problem · Corrections log
Comments (0)